» Articles » PMID: 35326520

Functional Decline in the Cancer Patient: A Review

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Mar 25
PMID 35326520
Authors
Affiliations
Soon will be listed here.
Abstract

A decline in functional status, an individual's ability to perform the normal activities required to maintain adequate health and meet basic needs, is part of normal ageing. Functional decline, however, appears to be accelerated in older patients with cancer. Such decline can occur as a result of a cancer itself, cancer treatment-related factors, or a combination of the two. The accelerated decline in function seen in older patients with cancer can be slowed, or even partly mitigated through routine assessments of functional status and timely interventions where appropriate. This is particularly important given the link between functional decline and impaired quality of life, increased mortality, comorbidity burden, and carer dependency. However, a routine assessment of and the use of interventions for functional decline do not typically feature in the long-term care of cancer survivors. This review outlines the link between cancer and subsequent functional decline, as well as potential underlying mechanisms, the tools that can be used to assess functional status, and strategies for its prevention and management in older patients with cancer.

Citing Articles

Factors associated with avoidable 30-day readmissions in patients with cancer: a single institution study.

Raiss M, Mehta K, Zhang X, Kabacinski A, Martorana D, Mischo J Support Care Cancer. 2025; 33(3):206.

PMID: 39971803 DOI: 10.1007/s00520-025-09215-0.


Relationships between patient-reported and clinician-rated toxicities and daily functioning in older adults with advanced cancer undergoing systemic therapy.

Culakova E, Mohamed M, Flannery M, Jensen-Battaglia M, Zhang Z, Ramsdale E Cancer. 2025; 131(4):e35766.

PMID: 39945245 PMC: 11822747. DOI: 10.1002/cncr.35766.


Relationship between incident cardiovascular disease and quality of life after a breast cancer diagnosis.

Vasbinder A, Wadden E, Cheng R, Barac A, Friese C, Sun Y J Cancer Surviv. 2025; .

PMID: 39909978 DOI: 10.1007/s11764-025-01757-w.


Extending Integration: Interventions Supporting Communication and Collaboration Between Patients with Neurological Diseases, Their Informal Caregivers and Healthcare Staff - a Scoping Review.

Degsell E, Al-Adili L, Gustavsson P, Brommels M, Dannapfel P Int J Integr Care. 2025; 25(1):5.

PMID: 39896786 PMC: 11784509. DOI: 10.5334/ijic.8577.


Lymph Node Dissection of Choice in Older Adult Patients with Gastric Cancer: A Systematic Review and Meta-Analysis.

Ramirez-Giraldo C, Avendano-Morales V, Van-Londono I, Melo-Leal D, Camargo-Areyanes M, Venegas-Sanabria L J Clin Med. 2025; 13(24.

PMID: 39768601 PMC: 11678213. DOI: 10.3390/jcm13247678.


References
1.
Reuben D, Siu A . An objective measure of physical function of elderly outpatients. The Physical Performance Test. J Am Geriatr Soc. 1990; 38(10):1105-12. DOI: 10.1111/j.1532-5415.1990.tb01373.x. View

2.
Bylow K, Hemmerich J, Mohile S, Stadler W, Sajid S, Dale W . Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study. Urology. 2011; 77(4):934-40. PMC: 3074039. DOI: 10.1016/j.urology.2010.11.024. View

3.
Neo J, Fettes L, Gao W, Higginson I, Maddocks M . Disability in activities of daily living among adults with cancer: A systematic review and meta-analysis. Cancer Treat Rev. 2017; 61:94-106. DOI: 10.1016/j.ctrv.2017.10.006. View

4.
Nipp R, Ruddy M, Fuh C, Zangardi M, Chio C, Kim E . Pilot Randomized Trial of a Pharmacy Intervention for Older Adults with Cancer. Oncologist. 2018; 24(2):211-218. PMC: 6369952. DOI: 10.1634/theoncologist.2018-0408. View

5.
Amidei C, Kushner D . Clinical implications of motor deficits related to brain tumors. Neurooncol Pract. 2019; 2(4):179-184. PMC: 6664611. DOI: 10.1093/nop/npv017. View